Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $25.0000 (-0.4%) ($25.0000 - $26.0000) on Sun. Dec. 2, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 14.32% (three month average) | RSI | 57 | Latest Price | $25.0000(-0.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -9.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CAPR price | CAPR will decline at least -7.16% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -7.16% (StdDev 14.32%) | Hourly BBV | 0 () | Intraday Trend | -3.8% | | | |
|
Resistance Level | $25.82 | 5 Day Moving Average | $25.07(-0.28%) | 10 Day Moving Average | $27.72(-9.81%) | 20 Day Moving Average | $25.82(-3.18%) | To recent high | -60% | To recent low | 47.1% | Market Cap | $N/A | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |